Unknown

Dataset Information

0

Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.


ABSTRACT: Nontyphoidal salmonellae, particularly Salmonella enterica serovar Typhimurium, are a major cause of invasive disease in Africa, affecting mainly young children and HIV-infected individuals. Glycoconjugate vaccines provide a safe and reliable strategy against invasive polysaccharide-encapsulated pathogens, and lipopolysaccharide (LPS) is a target of protective immune responses. With the aim of designing an effective vaccine against S. Typhimurium, we have synthesized different glycoconjugates, by linking O-antigen and core sugars (OAg) of LPS to the nontoxic mutant of diphtheria toxin (CRM(197)). The OAg-CRM(197) conjugates varied in (i) OAg source, with three S. Typhimurium strains used for OAg extraction, producing OAg with differences in structural specificities, (ii) OAg chain length, and (iii) OAg/CRM(197) ratio. All glycoconjugates were compared for immunogenicity and ability to induce serum bactericidal activity in mice. In vivo enhancement of bacterial clearance was assessed for a selected S. Typhimurium glycoconjugate by challenge with live Salmonella. We found that the largest anti-OAg antibody responses were elicited by (i) vaccines synthesized from OAg with the highest glucosylation levels, (ii) OAg composed of mixed- or medium-molecular-weight populations, and (iii) a lower OAg/CRM(197) ratio. In addition, we found that bactericidal activity can be influenced by S. Typhimurium OAg strain, most likely as a result of differences in OAg O-acetylation and glucosylation. Finally, we confirmed that mice immunized with the selected OAg-conjugate were protected against S. Typhimurium colonization of the spleen and liver. In conclusion, our findings indicate that differences in the design of OAg-based glycoconjugate vaccines against invasive African S. Typhimurium can have profound effects on immunogenicity and therefore optimal vaccine design requires careful consideration.

SUBMITTER: Rondini S 

PROVIDER: S-EPMC4333450 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.

Rondini S S   Micoli F F   Lanzilao L L   Gavini M M   Alfini R R   Brandt C C   Clare S S   Mastroeni P P   Saul A A   MacLennan C A CA  

Infection and immunity 20141229 3


Nontyphoidal salmonellae, particularly Salmonella enterica serovar Typhimurium, are a major cause of invasive disease in Africa, affecting mainly young children and HIV-infected individuals. Glycoconjugate vaccines provide a safe and reliable strategy against invasive polysaccharide-encapsulated pathogens, and lipopolysaccharide (LPS) is a target of protective immune responses. With the aim of designing an effective vaccine against S. Typhimurium, we have synthesized different glycoconjugates, b  ...[more]

Similar Datasets

| S-EPMC7677218 | biostudies-literature
| S-EPMC6151450 | biostudies-literature
| S-EPMC2626748 | biostudies-literature
| S-EPMC95209 | biostudies-literature
| S-EPMC3036662 | biostudies-literature
| S-EPMC4810497 | biostudies-literature
| S-EPMC7484078 | biostudies-literature
| S-EPMC3868846 | biostudies-literature
| S-EPMC3485933 | biostudies-literature
| S-EPMC3735059 | biostudies-literature